What is UroGen Pharma's current liabilities?

UroGen Pharma (URGN) reported current liabilities of $0 in Q1 2026.

How has UroGen Pharma's current liabilities changed year-over-year?

UroGen Pharma's current liabilities decreased by 100.0% year-over-year, from $483K to $0.

What is the long-term trend for UroGen Pharma's current liabilities?

Over 3 years (2021 to 2025), UroGen Pharma's current liabilities has grown at a 62.6% compound annual growth rate (CAGR), from $47K to -$202K.

UroGen Pharma URGN Current liabilities

Current liabilities at other companies

TG TherapeuticsTGTX

——

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Enterprise value$1.81B+80.9%

P/S12.3×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentLiabilities.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's current liabilities?: UroGen Pharma (URGN) reported current liabilities of $0 in Q1 2026.
How has UroGen Pharma's current liabilities changed year-over-year?: UroGen Pharma's current liabilities decreased by 100.0% year-over-year, from $483K to $0.
What is the long-term trend for UroGen Pharma's current liabilities?: Over 3 years (2021 to 2025), UroGen Pharma's current liabilities has grown at a 62.6% compound annual growth rate (CAGR), from $47K to -$202K.